On July 8, David presented a seminar entitled "ErbB Receptor Partial Agonists May Represent A Novel Paradigm for Cancer Drug Discovery" at the University of South Alabama Mitchell Cancer Institute.  The USA Mitchell Cancer Institute is a wonderful organization that features outstanding cancer care, basic cancer research, and translation of clinical problems to laboratory discovery to clinical application.